The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancerKiki M. H. Vangangelt, Wilma E. Mesker, Isabelle M.F. Heemskerk et al.|International Journal of Cancer|2020Cited by 72